Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abilify and Behavioral Therapy in Children with ASD
NCT02574741Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Aripiprazole + Behavioral Therapy with Placebo + Behavioral Therapy (2 arms). Primary endpoint: Number of words in a naturalistic language assessment at 12 weeks. Started Jun 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02574741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574741.